“治疗潜力”
用英语怎么说？

To achieve this, Olson co-founded Delix Therapeutics, employing a method known as function-oriented synthesis. By dissecting psychedelic molecules like DMT and making minute structural alterations, his team sought to isolate the components responsible for neuroplasticity while eliminating those that trigger hallucinations. This reductionist approach treated chemical compounds like complex machines whose individual parts could be swapped or refined. In their laboratory, researchers synthesized various analogues, utilizing fluorescent assays to weed out hallucinogenic compounds before testing them on living rodent neurons. Eventually, they identified a promising compound named zalsupindole. This molecule, which Olson categorized as a neuroplastogen, successfully stimulated dendritic growth without producing any hallucinogenic effects in animal models. The discovery suggested that the therapeutic potential of these compounds could indeed be harvested without subjecting patients to a mind-altering experience.

为了实现这一目标，奥尔森联合创立了Delix Therapeutics，并采用了一种被称为功能导向合成的方法。通过剖析像DMT这样的幻觉剂分子并进行微小的结构调整，他的团队试图分离出负责神经可塑性的成分，同时消除那些引发幻觉的成分。这种还原论方法将化学化合物视为复杂的机器，其各个部件可以进行更换或改进。在实验室里，研究人员合成了各种类似物，利用荧光检测来剔除致幻化合物，然后再在活体啮齿动物神经元上进行测试。最终，他们发现了一种名为zalsupindole的有前景的化合物。奥尔森将这种分子归类为神经塑料原，它成功刺激了树突生长，但在动物模型中没有产生任何致幻作用。这一发现表明，这些化合物的治疗潜力确实可以在不让患者经受精神活性体验的情况下被开发利用。